Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01061021 · ClinicalTrials.gov registry record · Phase 2
HIV Prevention Intervention for People Living With HIV/AIDS
A Phase 2 study of HIV Infections, sponsored by University of Connecticut.
- Completed
- Registry status
- Phase 2
- Development phase
- 490
- Enrollment target
- 1
- Study location
NCT01061021: Completed Phase 2 study of HIV Infections, sponsored by University of Connecticut.
NCT01061021 is a Phase 2 study of HIV Infections that has completed, run by University of Connecticut. The registered enrollment target is 490 participants, above the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (10% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01061021, a Phase 2 study of HIV Infections, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 490 participants
- Enrollment target
- 1
- Study location
Study Summary
HIV prevention interventions are needed to assist people living with HIV/AIDS to adhere to their medications and not transmit the virus to others. This study is testing a behavioral intervention designed to address both medication adherence and risk reduction in people living with HIV/AIDS. It is hypothesized that the experimental behavioral intervention will show improved medication adherence and safer sexual behaviors compared to a comparison group.
Conditions Studied
Interventions
- BEHAVIORAL In The Mix
- BEHAVIORAL Information Support Group
Study Locations (1)
Georgia
- Southeast HIV/AIDS Research and Evaluation Project - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 490 participants |
| Start Date | 2005-03 |
| Est. Completion | 2010-08 |
| Phase | Phase 2 |
What the finished NCT01061021 record still lists
NCT01061021 is an interventional study that assigns participants to a tested intervention. The registered 490 participants enrollment target is mid-sized for trials with a published cap, above the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (10% higher).
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which In The Mix is the first listed.
NCT01061021 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT01061021 about?
NCT01061021 is a clinical study titled "HIV Prevention Intervention for People Living With HIV/AIDS". HIV prevention interventions are needed to assist people living with HIV/AIDS to adhere to their medications and not transmit the virus to others. This study is testing a behavioral intervention designed to address both medication adherence and risk reduction in people living with HIV/AIDS. It is hy...
What is the current status of trial NCT01061021?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 490 participants. The study started on 2005-03. Estimated completion is 2010-08.
What conditions does trial NCT01061021 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT01061021?
The interventions under investigation include: In The Mix (BEHAVIORAL), Information Support Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT01061021?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01061021 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01061021's enrollment target sits among peer trials
490 66th of 542 higher than 477 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
RECRUITING · Phase 2
-
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
RECRUITING · Phase 2
-
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
RECRUITING · Phase 2
-
Imaging Immune Activation in HIV by PET-MR
RECRUITING · Phase 2
-
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a New Formulation of Cabotegravir Long-Acting Administered Intramuscularly in a 4-month Dosing Interval (Q4M)
ACTIVE NOT RECRUITING · Phase 2
-
A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04728893 · 490 participants · Phase 2
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
- NCT06238479 · 490 participants · Phase 1
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
- NCT06336928 · 490 participants
A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
- NCT06641414 · 490 participants · Phase 3
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia